Literature DB >> 19622825

Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.

Ronald C Petersen, John Q Trojanowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19622825      PMCID: PMC2792581          DOI: 10.1001/jama.2009.1073

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

Review 3.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

4.  Vitamin E and donepezil for the treatment of mild cognitive impairment.

Authors:  Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Journal:  N Engl J Med       Date:  2005-04-13       Impact factor: 91.245

5.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

Review 6.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 7.  Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.

Authors:  B Winblad; K Palmer; M Kivipelto; V Jelic; L Fratiglioni; L-O Wahlund; A Nordberg; L Bäckman; M Albert; O Almkvist; H Arai; H Basun; K Blennow; M de Leon; C DeCarli; T Erkinjuntti; E Giacobini; C Graff; J Hardy; C Jack; A Jorm; K Ritchie; C van Duijn; P Visser; R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

8.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

Authors:  Niklas Mattsson; Henrik Zetterberg; Oskar Hansson; Niels Andreasen; Lucilla Parnetti; Michael Jonsson; Sanna-Kaisa Herukka; Wiesje M van der Flier; Marinus A Blankenstein; Michael Ewers; Kenneth Rich; Elmar Kaiser; Marcel Verbeek; Magda Tsolaki; Ezra Mulugeta; Erik Rosén; Dag Aarsland; Pieter Jelle Visser; Johannes Schröder; Jan Marcusson; Mony de Leon; Harald Hampel; Philip Scheltens; Tuula Pirttilä; Anders Wallin; Maria Eriksdotter Jönhagen; Lennart Minthon; Bengt Winblad; Kaj Blennow
Journal:  JAMA       Date:  2009-07-22       Impact factor: 56.272

9.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Authors:  Clifford R Jack; Val J Lowe; Stephen D Weigand; Heather J Wiste; Matthew L Senjem; David S Knopman; Maria M Shiung; Jeffrey L Gunter; Bradley F Boeve; Bradley J Kemp; Michael Weiner; Ronald C Petersen
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

  9 in total
  16 in total

Review 1.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

Review 2.  Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Authors:  John Q Trojanowski; Hugo Vandeerstichele; Magdalena Korecka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Z Potter; Michael W Weiner; Clifford R Jack; William Jagust; Arthur W Toga; Virginia M-Y Lee; Leslie M Shaw
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

3.  Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Zaira Esposito; Francesco Di Lorenzo; Viola Giacobbe; Giulia Maria Sancesario; Giulia Bucchi; Sonia Bonnì; Sergio Bernardini; Roberto Sorge; Giuseppe Sancesario; Giorgio Bernardi; Carlo Caltagirone; Giacomo Koch
Journal:  J Neural Transm (Vienna)       Date:  2012-03-09       Impact factor: 3.575

Review 4.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

5.  Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment.

Authors:  M Mascalchi; A Ginestroni; V Bessi; N Toschi; S Padiglioni; S Ciulli; C Tessa; M Giannelli; L Bracco; S Diciotti
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-06       Impact factor: 3.825

6.  Leptin regulates amyloid β production via the γ-secretase complex.

Authors:  Dana M Niedowicz; Christa M Studzinski; Adam M Weidner; Thomas L Platt; Kristen N Kingry; Tina L Beckett; Annadora J Bruce-Keller; Jeffrey N Keller; M Paul Murphy
Journal:  Biochim Biophys Acta       Date:  2012-12-26

Review 7.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

Review 8.  The diagnosis and management of mild cognitive impairment: a clinical review.

Authors:  Kenneth M Langa; Deborah A Levine
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

9.  Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?

Authors:  Katie Palmer; Massimo Musicco; Carlo Caltagirone
Journal:  Int J Alzheimers Dis       Date:  2010-08-17

Review 10.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2013-08-07       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.